Literature DB >> 9478958

Expression of nitric-oxide synthase in rat Kupffer cells is regulated by cAMP.

S B Mustafa1, M S Olson.   

Abstract

Treatment of cultured rat Kupffer cells with lipopolysaccharide (LPS) resulted in a time-dependent increase in the expression of the inducible isoform of nitric-oxide synthase (iNOS). Agents that elevated intracellular cAMP levels (e.g. forskolin, dibutyryl cAMP, cholera toxin, and isoproterenol) markedly decreased nitrite production and iNOS protein formation by LPS-stimulated Kupffer cells. Furthermore, inhibition of LPS-induced nitrite formation and iNOS protein levels by these agents was enhanced in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine. Forskolin, the most potent inhibitor of LPS-induced nitrite formation by Kupffer cells, decreased iNOS mRNA levels in a time-dependent manner. Time course studies indicated that forskolin was most effective at inhibiting LPS-induced nitrite formation and iNOS mRNA levels by Kupffer cells when added before LPS. Message stability studies established that forskolin did not enhance the rate of decay of LPS-induced iNOS mRNA. Nuclear run-on assays revealed that forskolin decreased LPS-induced transcription of the iNOS gene. Treatment of Kupffer cells with LPS induced the translocation of the p65 subunit of nuclear factor kappaB (NF-kappaB) into the nucleus, and this process was abolished by forskolin. In addition, the LPS-dependent degradation of IkappaBalpha was not observed in forskolin-treated cells; the levels of the p65 subunit of NF-kappaB were minimal in the nucleus at the same time. Also, we observed that forskolin induced transcription of the IkappaBalpha gene in a time-dependent manner and in addition up-regulated LPS-induced IkappaBalpha mRNA levels. Taken together, this study indicates that the attenuation of LPS-induced iNOS formation in Kupffer cells by elevated intracellular cAMP levels occurs by preventing the degradation of IkappaBalpha which suppresses the activation of NF-kappaB and inhibits the onset of transcription of the iNOS gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9478958     DOI: 10.1074/jbc.273.9.5073

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP.

Authors:  M Cavicchi; B J Whittle
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis.

Authors:  Anna-Aikaterini Neri; Ismene A Dontas; Dimitrios C Iliopoulos; Theodore Karatzas
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  Cyclic AMP prolongs graft survival by suppressing apoptosis and inflammatory gene expression in acute cardiac allograft rejection.

Authors:  Jie-Young Lee; Jung Hwan Kim; Gibong Chae; Bong-Ki Lee; Kwon-Soo Ha; Young-Geun Kwon; Young-Myeong Kim
Journal:  Exp Mol Med       Date:  2010-01-31       Impact factor: 8.718

Review 4.  Cyclic AMP: a selective modulator of NF-κB action.

Authors:  Sarah Gerlo; Ron Kooijman; Ilse M Beck; Krzysztof Kolmus; Anneleen Spooren; Guy Haegeman
Journal:  Cell Mol Life Sci       Date:  2011-07-09       Impact factor: 9.261

5.  Activation of cyclic adenosine monophosphate-dependent protein kinase a signaling prevents liver ischemia/reperfusion injury in mice.

Authors:  Haofeng Ji; Xiu-da Shen; Yu Zhang; Feng Gao; Cynthia Y Huang; William W Chang; Coney Lee; Bibo Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2012-06       Impact factor: 5.799

6.  Inhibitor of nuclear factor-kappaB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expression.

Authors:  P J Kamthong; M Wu
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

7.  Apoptosis of rat gastric mucosa and of primary cultures of gastric epithelial cells by indomethacin: role of inducible nitric oxide synthase and interleukin-8.

Authors:  S Imamine; F Akbar; Y Mizukami; H Matsui; M Onji
Journal:  Int J Exp Pathol       Date:  2001-08       Impact factor: 1.925

8.  Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.

Authors:  Muayad Albadrani; Ratanesh K Seth; Sutapa Sarkar; Diana Kimono; Ayan Mondal; Dipro Bose; Dwayne E Porter; Geoff I Scott; Bryan Brooks; Samir Raychoudhury; Mitzi Nagarkatti; Prakash Nagarkatti; Yvon Jule; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-08-08       Impact factor: 4.052

9.  Indomethacin can induce cell death in rat gastric parietal cells through alteration of some apoptosis- and autophagy-associated molecules.

Authors:  Sahar M Gebril; Yuko Ito; Masa-Aki Shibata; Kentaro Maemura; Eman E Abu-Dief; Mahmoud R A Hussein; Usama M Abdelaal; Hoda M Elsayed; Yoshinori Otsuki; Kazuhide Higuchi
Journal:  Int J Exp Pathol       Date:  2020-09-28       Impact factor: 1.925

10.  Gastric mucosal inflammatory responses toHelicobacter pylori lipopolysaccharide: suppression of caspase-3 and nitric oxide synthase-2 by omeprazole and sucralfate.

Authors:  B L Slomiany; J Piotrowski; A Slomiany
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.